Valuation: AddLife AB

Market Cap 19.83B 2.09B 1.79B 1.68B 1.54B 2.88B 200B 2.92B 7.73B 101B 7.86B 7.69B 333B P/E 2026 *
37.1x
P/E 2027 * 29.2x
Enterprise Value 23.42B 2.47B 2.12B 1.98B 1.81B 3.4B 237B 3.45B 9.13B 119B 9.28B 9.08B 393B EV / Sales 2026 *
2.15x
EV / Sales 2027 * 1.96x
Free-Float
90.8%
Yield 2026 *
1.03%
Yield 2027 * 1.26%
1 day+18.98%
1 week+166.67%
Current month+166.67%
1 month+166.67%
3 months+166.67%
6 months+428.97%
Current year+428.97%
Current year 15.75
Extreme 15.75
42
1 year 15.75
Extreme 15.75
42
3 years 15.75
Extreme 15.75
42
5 years 7.94
Extreme 7.94
42
10 years 7.94
Extreme 7.94
42
Manager TitleAgeSince
Chief Executive Officer 54 31/12/2021
Director of Finance/CFO 56 31/12/2021
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 59 04/03/2015
Director/Board Member 57 31/12/2014
Director/Board Member 62 31/12/2014
Change 5-day change 1-year change 3-year change Capi.($)
+18.98%+166.67% - - 2.09B
+2.19%+4.84%-12.03%+10.95% 202B
+1.14%+2.28%+0.69%+11.56% 119B
+1.06%+1.34%+8.69%+78.91% 60.69B
0.00%-5.70%+29.16%+55.35% 52.38B
+2.33%+4.69%-3.84%-30.71% 52.3B
+2.35%+2.89%+12.25%-11.53% 34.85B
+5.16%-4.14% - - 30.06B
-0.20%+1.05%+42.46%-10.17% 24.85B
+1.03%-0.94%-1.24%+24.84% 23.84B
Average +3.40%+0.28%+9.52%+16.15% 66.7B
Weighted average by Cap. +1.76%+1.90%+1.69%+16.85%

Financials

2026 *2027 *
Net sales 10.9B 1.15B 986M 923M 845M 1.59B 110B 1.61B 4.25B 55.34B 4.32B 4.23B 183B 11.62B 1.23B 1.05B 983M 900M 1.69B 117B 1.71B 4.53B 58.97B 4.61B 4.51B 195B
Net income 535M 56.45M 48.36M 45.25M 41.42M 77.73M 5.4B 78.76M 208M 2.71B 212M 207M 8.97B 679M 71.71M 61.43M 57.48M 52.61M 98.74M 6.86B 100M 265M 3.45B 269M 263M 11.4B
Net Debt 3.59B 379M 325M 304M 278M 522M 36.26B 529M 1.4B 18.21B 1.42B 1.39B 60.24B 2.91B 308M 264M 247M 226M 424M 29.44B 429M 1.14B 14.79B 1.16B 1.13B 48.91B
Logo AddLife AB
AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
Employees
2,360
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
162.70SEK
Average target price
198.33SEK
Spread / Average Target
+21.90%

Quarterly revenue - Rate of surprise